Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

iCLAS™ for Persistent Atrial Fibrillation

NCT: NCT04061603 · COMPLETED

NCT IDNCT04061603
StatusCOMPLETED
Start Date2019-12-09
Completion2024-08-30
SponsorAdagio Medical (INDUSTRY)
First posted
Last updated

Brief Summary

Clinical study to evaluate the safety and efficacy of the Adagio AF Cryoablation System (iCLAS™) in the ablation treatment of symptomatic, persistent atrial fibrillation (PsAF). Data will be used to support a pre-market application (PMA)

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑